ST VINCENT DE PAUL COMM PHARMACY
Balance Sheet
Fiscal Year Start:
Oct 1
Assets in 2024 (Year End)
$713,366
Cash & Equivalents
90%
Property, Plant, & Equipment (net)
6%
Inventories
2%
Receivables (Non-Related)
1%
Prepaid Expenses
<1%
Other Assets
<1%
Related-Party Receivables
0%
Investments
0%
Liabilities in 2024 (Year End)
$9,302
Other Liabilities
55%
Payables & Accruals
45%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$77,722
$644,129
+729%
Receivables (Non-Related)
$102
$7,469
+7223%
Related-Party Receivables
-
-
-
Inventories
$3,831
$13,320
+248%
Prepaid Expenses
$5,834
$3,431
-41%
Investments
-
-
-
Property, Plant, & Equipment (net)
$50,940
$41,627
-18%
Other Assets
$39,953
$3,390
-92%
Total Assets
$178,382
$713,366
+300%
Liabilities
2023
2024
Change
Payables & Accruals
$10,425
$4,192
-60%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
$5,110
-
Total Liabilities
$10,425
$9,302
-11%
Net assets
2023
2024
Change
Restricted Net Assets
$1,129
$65,165
+5672%
Unrestricted Net Assets
$166,828
$638,899
+283%
Net assets
2023
2024
Change
Net assets
+$167,957
+$704,064
+319%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)